Bayer to Pull Glyphosate Products, Including Roundup, From U.S. Home and Garden Market

Bayer will no longer sell glyphosate-containing products to U.S. home gardeners, the company announced on Thursday.

The move comes as the company currently faces around 30,000 legal claims from customers who believe use of these products — including the flagship Roundup — caused them to develop cancer, as AgWeb reported.

Bayer’s decision comes in response to the many lawsuits related to glyphosate that it inherited when it acquired Monsanto in 2018. Juries sided with the plaintiffs in three highly-watched trials before Bayer settled around 95,000 cases in 2020 to the tune of $10 billion. That settlement, which was one of the largest in U.S. history, allowed Bayer to continue to sell Roundup without any warnings. However, the company still faces further litigation, and said it decided to pull the product from residential use in order to prevent more. More than 90 percent of recent claims come from the residential home and garden market, AgWeb reported.

“This move is being made exclusively to manage litigation risk and not because of any safety concerns,” the company said when it announced its decision.

The products will be replaced with different active ingredients beginning in 2023, following reviews by the EPA and state regulatory bodies. January 2023 was the earliest the change could reasonably be implemented, Bayer Crop Science Division president Liam Condon told AgWeb.

“This is from a regulatory and logistical point of view (of what’s) possible,” Condon said during a conference call with investors, as AgWeb reported.